CoChat

A Lipid Nanoparticle System Improves siRNA Efficacy in RPE Cells and a Laser-Induced Murine CNV Model

Liu, Hong-an, Liu, Yu-ling, Ma, Zhi-zhong, Wang, Jian-cheng, Zhang, Qiang · 2011 · Investigative Opthalmology & Visual Science

The DOI matches its Crossref record; 19 of the 19 references it cites were found in a registry or an index.

Abstract

PURPOSE: To explore the possibility of the PEGylated liposome-protamine-hyaluronic acid nanoparticles (PEG-LPH-NP) loaded with siRNA (PEG-LPH-NP-S) in ARPE19 cells and a laser-induced rat model for the treatment of choroidal neovascularization (CNV). METHODS: PEG-LPH-NP-S was characterized by dynamic light scattering and transmission electron microscopy (TEM). The encapsulation efficiency of siRNA in PEG-LPH-NP was analyzed by ultracentrifugation, whereas the protection of siRNA by PEG-LPH-NP was evaluated by electrophoresis. Human RPE cells (ARPE19) were used as the cell model for the studies of cellular uptake and the inhibition of VEGFR1 expression, visualized by a laser scanning confocal microscope. The area of CNV in the laser-induced rat model after intravitreous injection was measured. The distribution of the lipid nanoparticles in the retina after intravitreous administration was investigated by fluorescence microscopy. Finally, the TUNEL test and morphologic observation of the retina were conducted. RESULTS: It was indicated that PEG-LPH-NP-S was approximately 132 nm in particle size with a positive charge of approximately 20 mV, whereas the encapsulation efficiency of siRNA in PEG-LPH-NP was >95%. PEG-LPH-NP could protect the siRNA load and could facilitate the intracellular delivery of fluorescein-labeled siRNA to ARPE19 cells. VEGFR1 expression in ARPE19 cells could be inhibited, and the CNV area in the murine model could be reduced more effectively by PEG-LPH-NP-S compared with naked siRNA and by PEG-LPH-NP with negative siRNA. It seems that the toxicity of PEG-LPH-NP-S on the rat retina is low, based on the results of TUNEL testing and morphologic observation. CONCLUSIONS: PEG-LPH-NP may be a promising lipid nanoparticle system for the siRNA treatment of CNV.

Overview

Integrity signals

Registry

Crossref · 10.1167/iovs.10-5891

Cites

19 of 19 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 19 references

Cited by

See all 105

Metadata

Authors
Liu, H.-A., Liu, Y.-L., Ma, Z.-Z., Wang, J.-C., & Zhang, Q.
Affiliations
  • Peking University (CN)
  • From the Peking University Eye Center, Peking University Third Hospital, Peking University, Beijing, China; and
  • the State Key Laboratory of Natural and Biomimetic Drugs, School of Pharmaceutical Sciences, Peking University, Beijing, China.
Venue
Investigative Opthalmology & Visual Science
Published
2011-06-30
Volume
52
Issue
7
Pages
4789
ISSN
  • 0146-0404 (ISSN-L)
  • 1552-5783
OpenAlex
W1970980357
Cited by
97
References
19
Citations by year
2026: 6 · 2025: 5 · 2024: 6 · 2023: 7 · 2022: 7 · 2021: 7 · 2020: 7 · 2019: 6 · 2018: 5 · 2017: 4 · 2016: 10 · 2015: 9 · 2014: 6 · 2013: 5 · 2012: 5
FWCI
2.21
Type
journal article
Language
en
Open access
closed
Locations
  • Investigative Ophthalmology & Visual Science (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › RNA Interference and Gene Delivery
  • Physical Sciences › Materials Science › Biomaterials › Nanoparticle-Based Drug Delivery
  • Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmaceutical Science › Advanced Drug Delivery Systems
Keywords
lipid nanoparticles, siRNA delivery, choroidal neovascularization, PEGylated liposomes, protamine, hyaluronic acid, intravitreal injection, nanoparticle toxicity, retinal distribution
MeSH terms
Animals, Cells, Cultured, Disease Models, Animal, Humans, Liposomes, Male, Microscopy, Fluorescence, Rats, Inbred BN, Treatment Outcome, Apoptosis, Microscopy, Confocal, Choroidal Neovascularization, In Situ Nick-End Labeling, RNA, Small Interfering, Vascular Endothelial Growth Factor Receptor-1, Microscopy, Electron, Transmission, Rats, Nanoparticles, Retinal Pigment Epithelium, Young Adult, Intravitreal Injections

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.